ATE90563T1 - Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie. - Google Patents

Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie.

Info

Publication number
ATE90563T1
ATE90563T1 AT89119837T AT89119837T ATE90563T1 AT E90563 T1 ATE90563 T1 AT E90563T1 AT 89119837 T AT89119837 T AT 89119837T AT 89119837 T AT89119837 T AT 89119837T AT E90563 T1 ATE90563 T1 AT E90563T1
Authority
AT
Austria
Prior art keywords
hecogenin
ester derivatives
treatment
medicinal preparation
benign prostate
Prior art date
Application number
AT89119837T
Other languages
German (de)
English (en)
Inventor
August S Streber
Original Assignee
Boots Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Pharma Gmbh filed Critical Boots Pharma Gmbh
Application granted granted Critical
Publication of ATE90563T1 publication Critical patent/ATE90563T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
AT89119837T 1988-11-15 1989-10-25 Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie. ATE90563T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3838716A DE3838716A1 (de) 1988-11-15 1988-11-15 Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie
EP89119837A EP0369216B1 (de) 1988-11-15 1989-10-25 Arzneimittelzubereitung aus Esterderivaten des Hecogenins und dessen Verwendung zur Behandlung von benigner Prostatahyperplasie

Publications (1)

Publication Number Publication Date
ATE90563T1 true ATE90563T1 (de) 1993-07-15

Family

ID=6367236

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89119837T ATE90563T1 (de) 1988-11-15 1989-10-25 Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie.

Country Status (9)

Country Link
US (1) US5002939A (pt)
EP (1) EP0369216B1 (pt)
JP (1) JP2562210B2 (pt)
AT (1) ATE90563T1 (pt)
BE (2) BE1002504A3 (pt)
DE (2) DE3838716A1 (pt)
ES (1) ES2057054T3 (pt)
GR (1) GR3008170T3 (pt)
IT (1) IT1229272B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE314057T1 (de) * 1998-03-26 2006-01-15 Phytopharm Plc Smilagenin und anzurogenin-d zur behandlung der alzheimerischen krankheit
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6241987B1 (en) * 1998-08-20 2001-06-05 Amway Corporation Dietary supplement containing saw palmetto, pumpkin seed, and nettle root
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
NZ588708A (en) 2008-04-18 2012-09-28 Reata Pharmaceuticals Inc 2-cyano steroid derivatives including an anti-inflammatory pharmacore
JPWO2018042825A1 (ja) * 2016-08-30 2019-01-31 パナソニックＩｐマネジメント株式会社 色変換素子

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA582813A (en) * 1959-09-08 Elks Joseph 3.beta., 12.beta.-DIHYDROXY-11-OXO-23-BROMO-5.alpha., 22.alpha.-SPIROSTAN
CA985172A (en) * 1972-10-06 1976-03-09 Dushan M. Dvornik Compositions and methods for reducing blood cholesterol
US3935194A (en) * 1974-01-22 1976-01-27 Omni Research Incorporated Separation of hecogenin-tigogenin mixtures
DE2759171A1 (de) * 1977-12-31 1979-07-12 Roecar Holdings Nv Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
DE2926463A1 (de) * 1978-07-05 1980-01-24 Roecar Holdings Nv Spiroketaline und ihre verwendung
GB2024624A (en) * 1978-07-05 1980-01-16 Roecar Holdings Nv Anti inflammatory spiroketalins
DE3888378T2 (de) * 1987-04-03 1994-09-29 Merck & Co Inc Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.

Also Published As

Publication number Publication date
EP0369216A3 (en) 1990-11-07
EP0369216B1 (de) 1993-06-16
JPH02180830A (ja) 1990-07-13
IT1229272B (it) 1991-07-26
ES2057054T3 (es) 1994-10-16
IT8920466A0 (it) 1989-05-11
EP0369216A2 (de) 1990-05-23
JP2562210B2 (ja) 1996-12-11
US5002939A (en) 1991-03-26
BE1002024A6 (fr) 1990-05-22
DE3838716C2 (pt) 1990-09-20
BE1002504A3 (fr) 1991-03-05
GR3008170T3 (pt) 1993-09-30
DE3838716A1 (de) 1990-05-17
DE58904722D1 (de) 1993-07-22

Similar Documents

Publication Publication Date Title
DE69421778D1 (de) Verwendung von wirksamen Mengen von aktiven Stoffen zur Behandlung von Mischhaut
NO20006462L (no) Anvendelse av fumarsyrederivater i transplantasjonsmedisin
ATE209908T1 (de) RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
DE69715358D1 (de) Topische Zusammensetzung enhaltend Pulver aus Safflorsamen zur Behandlung von rheumatoiden Arthritis Krankheiten und Menopause
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE69710065D1 (de) Androsten-derivate
ATE90563T1 (de) Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie.
ES2186898T3 (es) Metodos para evitar problemas de esqueleto en aves de corral.
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
ATA903489A (de) Protoporphyrinogeninhibitoren und deren verwendung in zusammensetzungen zur erkennung und behandlung von tumoren
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
ATE247466T1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
DE59209823D1 (de) Bilobalid enthaltende pharmazeutische zubereitungen zur behandlung von spannungs- und angstzuständen
ATA901396A (de) Verwendung von melatonin zur behandlung von an medikamentensucht leidenden patienten
IT1141039B (it) Formulazioni biodegradabili che favoriscono la crescita e procedimento di trattamento
DE69721484D1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
DE60043247D1 (de) Verwendung von Peroxidlipiden zur Vorbeugung und/oder Behandlung von irritierenden Effekten eines Wirkstoffes
DE69133542D1 (de) Katheter zur Behandlung von Prostaterkrankungen
DE69430807D1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
ATE96150T1 (de) Thioester und dessen verwendung zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischaemie und von reperfusionsyndromen.

Legal Events

Date Code Title Description
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee